Panacea Acquisition Corp. II
Index- P/E- EPS (ttm)-0.00 Insider Own3.06% Shs Outstand23.55M Perf Week0.05%
Market Cap203.41M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float13.80M Perf Month1.05%
Income-0.10M PEG- EPS next Q- Inst Own92.60% Short Float / Ratio3.64% / 5.90 Perf Quarter3.27%
Sales- P/S- EPS this Y- Inst Trans0.60% Short Interest0.50M Perf Half Y4.28%
Book/sh7.11 P/B1.42 EPS next Y- ROA-0.10% Target Price- Perf Year0.75%
Cash/sh0.00 P/C2034.12 EPS next 5Y- ROE-0.10% 52W Range9.64 - 10.55 Perf YTD0.65%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-4.12% Beta-
Dividend %- Quick Ratio1.00 Sales past 5Y- Gross Margin- 52W Low4.93% ATR0.06
Employees- Current Ratio1.00 Sales Q/Q- Oper. Margin- RSI (14)63.06 Volatility0.20% 0.68%
OptionableNo Debt/Eq0.00 EPS Q/Q406.00% Profit Margin- Rel Volume0.30 Prev Close10.12
ShortableNo LT Debt/Eq0.00 Earnings- Payout- Avg Volume85.17K Price10.11
Recom- SMA200.30% SMA501.27% SMA2003.03% Volume13,900 Change-0.05%
Apr-30-22 04:43PM
Dec-02-21 11:58AM
Apr-06-21 10:19PM
Feb-10-21 04:05PM
Jan-20-21 06:28PM
07:30AM Loading…
Oct-21-20 07:30AM
Panacea Acquisition Corp. II does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses in the biotechnology sector. The company was incorporated in 2021 and is based in San Francisco, California.